Cetuximab and malignant neoplasm progression Patient Reports February 11, 2012

Cetuximab Side Effects Report #4865681-7
Cetuximab side effect was reported by a Health Professional from GERMANY on Dec 21, 2005. Male patient, 72 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, renal failure. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient died on 12/19/2005.

Cetuximab Side Effects Report #5345725-9
Cetuximab side effect was reported by a Health Professional from BELGIUM on May 31, 2007. Male patient, 62 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: keratitis, malignant neoplasm progression, trichomegaly. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL, DOCETAXEL. Patient recovered.

Cetuximab Side Effects Report #5316484-0
Cetuximab side effect was reported by a Health Professional from BELGIUM on Apr 25, 2007. Male patient, 61 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: keratitis, malignant neoplasm progression, trichomegaly. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient recovered.

Cetuximab Side Effects Report #4806388-1
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Aug 08, 2005. Male patient, 54 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, FLUOROURACIL. Patient was hospitalized and became disabled. Patient died on 08/27/2005.

Cetuximab Side Effects Report #5237722-9
Cetuximab side effect was reported by a Health Professional from GERMANY on Feb 05, 2007. Male patient, 48 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, hyperbilirubinaemia, hypercalcaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died.

Cetuximab Side Effects Report #5307587-5
Cetuximab side effect was reported by a Health Professional from GERMANY on Apr 25, 2007. Male patient, 48 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, hyperbilirubinaemia, hypercalcaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 03/27/2006.

Cetuximab Side Effects Report #5321080-5
Cetuximab side effect was reported by a Health Professional from GERMANY on May 09, 2007. Male patient, 48 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, hyperbilirubinaemia, hypercalcaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 03/27/2006.

Cetuximab Side Effects Report #5329966-2
Cetuximab side effect was reported by a Health Professional from GERMANY on May 16, 2007. Male patient, 48 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, hyperbilirubinaemia, hypercalcaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 03/27/2006.

Cetuximab Side Effects Report #5340287-4
Cetuximab side effect was reported by a Health Professional from GERMANY on May 14, 2007. Male patient, 48 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, hyperbilirubinaemia, hypercalcaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 03/27/2006.

Cetuximab Side Effects Report #5357501-1
Cetuximab side effect was reported by a Health Professional from GERMANY on June 08, 2007. Male patient, 48 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, hyperbilirubinaemia, hypercalcaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 03/27/2006.

Cetuximab Side Effects Report #5359277-0
Cetuximab side effect was reported by a Health Professional from GERMANY on June 12, 2007. Male patient, 48 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, hyperbilirubinaemia, hypercalcaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 03/27/2006.

Cetuximab Side Effects Report #5379166-5
Cetuximab side effect was reported by a Health Professional from GERMANY on June 25, 2007. Male patient, 48 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, hyperbilirubinaemia, hypercalcaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 03/27/2006.

Cetuximab Side Effects Report #5675794-8
Cetuximab side effect was reported by a Health Professional from GERMANY on Mar 17, 2008. Male patient, 48 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, hyperbilirubinaemia, hypercalcaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 03/27/2006.

Cetuximab Side Effects Report #5697807-X
Cetuximab side effect was reported by a Health Professional from GERMANY on Apr 02, 2008. Male patient, 48 years of age, was diagnosed with squamous cell carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, hyperbilirubinaemia, hypercalcaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 03/27/2006.

Cetuximab Side Effects Report #5564288-6
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Dec 14, 2007. Female patient, 65 years of age, weighting 116.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: lung disorder, lymphadenopathy, malignant neoplasm progression, metastases to liver. Cetuximab dosage: 200MG/M2 IV WEEKLY. During the same period patient was treated with TARCEVA. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5664043-2
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Mar 11, 2008. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: febrile neutropenia, hypotension, hypoxia, international normalised ratio increased, malignant neoplasm progression, respiratory failure. Cetuximab dosage: unknown. During the same period patient was treated with IXABEPILONE, REGLAN, MEGACE, SENOKOT, MORPHINE, PROCHLORPERAZINE, CEFTAZIDIME. Patient was hospitalized. Patient died on 09/30/2007.

Cetuximab Side Effects Report #5413872-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 10, 2007. Male patient, 61 years of age, weighting 143.3 lb, was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: abdominal pain

, duodenal perforation, hypokalaemia, hypophosphataemia, malignant neoplasm progression, obstruction gastric, thrombosis, vomiting. Cetuximab dosage: CYC1-400MG/M2IV,D1.250MG/M2IV,D8,15,22.CYC2-.250MG/M2IV,D8,15,22. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, DANAPAROID, HYDROMORPH CONTIN, OMEPRAZOLE, SENOKOT, HYDROMORPHONE, OXYCONTIN. Patient was hospitalized. Patient died on 01/14/2007.

Cetuximab Side Effects Report #4677851-1
Cetuximab side effect was reported by a Consumer or non-health professional from on May 02, 2005. Male patient, 56 years of age, weighting 185.2 lb, was diagnosed with pancreatic carcinoma, thrombosis and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain

, cerebral haemorrhage, disseminated intravascular coagulation, malignant neoplasm progression, platelet count decreased, white blood cell count decreased. Cetuximab dosage: 3745 MG TOTAL DOSE THIS COURSE.. During the same period patient was treated with DOCETAXEL, IRINOTECAN, ENOXAPARIN. Patient was hospitalized. Patient died on 04/23/2005.

Cetuximab Side Effects Report #5227031-6
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: caecitis, diarrhoea, infection

, malignant neoplasm progression, no therapeutic response. Cetuximab dosage: unknown. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, PROTONIX, DARVOCET, LANTUS, NOVOLOG, VIOKASE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5668742-8
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2008. Male patient, 69 years of age, weighting 173.7 lb, was diagnosed with oesophageal carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: fatigue, inadequate analgesia, malignant neoplasm progression, oesophageal cancer metastatic. Cetuximab dosage: 250 MG/M2 IV. During the same period patient was treated with LORDAZEPAM, CLINDAMYCIN, WARFARIN, FENTANYL, OXYCODONE, VALACYCLOVIR, ATIVAN, COMPAZINE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4828293-7
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Nov 14, 2005. Male patient, weighting 138.9 lb, was diagnosed with oesophageal carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: disease progression, jaundice

, malignant neoplasm progression, metastases to spine, oesophageal cancer metastatic, pain

. Cetuximab dosage: unknown. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4870113-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Dec 29, 2005. Male patient, weighting 130.1 lb, was diagnosed with oesophageal carcinoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anastomotic leak, duodenal stenosis, intestinal obstruction, malignant neoplasm progression, nausea

, stent occlusion. Cetuximab dosage: unknown. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4808948-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Mar 24, 2003. Female patient, 52 years of age, was diagnosed with non-small cell lung cancer stage iv, pain

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Cetuximab dosage: 400 MG/250 MG/M2. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, ROXANOL. Patient died on 09/01/2002.

Cetuximab Side Effects Report #4943557-4
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 29, 2005. Male patient, 81 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation

, blood albumin decreased, malignant neoplasm progression, mucosal inflammation, pneumonia aspiration, rash

, stomatitis. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, AMBIEN, DOXYCYCLINE, IMODIUM, KEFLEX. Patient was hospitalized. Patient died on 01/25/2006.

Cetuximab Side Effects Report #4688706-0
Cetuximab side effect was reported by a Health Professional from on May 10, 2005. Male patient, 72 years of age, weighting 167.6 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: abdominal discomfort, constipation

, malignant neoplasm progression, myocardial infarction, nausea

. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, LASIX, TYLENOL, CARDIZEM. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4681175-6
Cetuximab side effect was reported by a Health Professional from on May 27, 2005. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer, hypertension, diabetes mellitus non-insulin-dependent, hypomagnesaemia, vomiting and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood magnesium decreased, malignant neoplasm progression, ventricular arrhythmia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, LISINOPRIL, HYDROCHLOROTHIAZIDE, GLYBURIDE, MAGNESIUM OXIDE, AVANDIA, COMPAZINE, TYLENOL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4687599-5
Cetuximab side effect was reported by a Health Professional from on May 27, 2005. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer, hypertension, diabetes mellitus non-insulin-dependent, hypomagnesaemia, vomiting and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood magnesium decreased, blood sodium decreased, conduction disorder, extrasystoles, malignant neoplasm progression, ventricular arrhythmia, ventricular extrasystoles. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, LISINOPRIL, HYDROCHLOROTHIAZIDE, GLYBURIDE, MAGNESIUM OXIDE, AVANDIA, COMPAZINE, TYLENOL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4718478-2
Cetuximab side effect was reported by a Health Professional from UNITED STATES on May 27, 2005. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer, hypertension, diabetes mellitus non-insulin-dependent, hypomagnesaemia, vomiting and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood magnesium decreased, malignant neoplasm progression, ventricular arrhythmia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, LISINOPRIL, HYDROCHLOROTHIAZIDE, GLYBURIDE, MAGNESIUM OXIDE, AVANDIA, COMPAZINE, TYLENOL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4733278-5
Cetuximab side effect was reported by a Health Professional from UNITED STATES on May 27, 2005. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer, hypertension, diabetes mellitus non-insulin-dependent, hypomagnesaemia, vomiting and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood magnesium decreased, malignant neoplasm progression, ventricular arrhythmia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, LISINOPRIL, HYDROCHLOROTHIAZIDE, GLYBURIDE, MAGNESIUM OXIDE, AVANDIA, COMPAZINE, TYLENOL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4746117-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on May 27, 2005. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer, hypertension, diabetes mellitus non-insulin-dependent, hypomagnesaemia, vomiting and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood magnesium decreased, blood sodium decreased, disease progression, extrasystoles, hypomagnesaemia, malignant neoplasm progression, supraventricular extrasystoles, ventricular arrhythmia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, LISINOPRIL, HYDROCHLOROTHIAZIDE, GLYBURIDE, MAGNESIUM OXIDE, AVANDIA, COMPAZINE, TYLENOL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5128927-6
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: deep vein thrombosis

, malignant neoplasm progression, renal failure, respiratory failure. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, ATENOLOL, SURFAK, PRAVACHOL, LASIX, MARINOL, MS CONTIN. Patient was hospitalized. Patient died on 12/11/2005.

Cetuximab Side Effects Report #4835904-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Nov 11, 2005. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, renal failure. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, CONTRAST AGENT, HYDROCHLOROTHIAZIDE, ASPIRIN, GLUCOTROL, METFORMINE. Patient was hospitalized. Patient died on 11/11/2005.

Cetuximab Side Effects Report #4847331-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Nov 11, 2005. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, renal failure. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, CONTRAST AGENT, HYDROCHLOROTHIAZIDE, ASPIRIN, GLUCOTROL, METFORMINE. Patient was hospitalized. Patient died on 11/11/2005.

Cetuximab Side Effects Report #5207370-5
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 09, 2007. Male patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: cardiac arrest

, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PREDNISONE, LOVENOX, OXYGEN. Patient died on 08/03/2006.

Cetuximab Side Effects Report #5226389-1
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2007. Male patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: cardiac arrest

, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PREDNISONE, LOVENOX, OXYGEN. Patient died on 08/03/2006.

Cetuximab Side Effects Report #5256150-3
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 01, 2007. Male patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: cardiac arrest

, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PREDNISONE, LOVENOX, OXYGEN. Patient died on 08/03/2006.

Cetuximab Side Effects Report #5536034-3
Cetuximab side effect was reported by a Health Professional from GERMANY on Nov 27, 2007. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pulmonary embolism

. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE. Patient recovered.

Cetuximab Side Effects Report #5632515-2
Cetuximab side effect was reported by a Health Professional from GERMANY on Feb 15, 2008. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pulmonary embolism

. Cetuximab dosage: STRENGTH 2MG/ML. MOST RECENT INFUSION 21APR06. During the same period patient was treated with CISPLATIN, VINORELBINE. Patient recovered.

Cetuximab Side Effects Report #4721939-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on May 05, 2005. Female patient, 68 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer, anaemia, intravenous catheter management, antiemetic supportive care and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, hypokalaemia, hypomagnesaemia, hypotension, malignant neoplasm progression, pleural effusion, supraventricular tachycardia. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, ARANESP, HEPARIN, ZANTAC, DECADRON, ALOXI. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #6110294-2
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Mar 06, 2009. Female patient, 67 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: angina pectoris, atrial fibrillation

, cardiac failure, malignant neoplasm progression, pneumonia

. Cetuximab dosage: unknown. During the same period patient was treated with LIPITOR, ISOSORBIDE MONONITRATE, TOPROL, ASPIRIN, VENTOLIN, OXYBUTYNIN CHLORIDE, NEXIUM, GLYBURIDE. Patient was hospitalized. Patient died on 03/04/2009.

Cetuximab Side Effects Report #4834377-X
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Nov 14, 2005. Male patient, 66 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer, atrial fibrillation

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, malignant neoplasm progression, mental status changes, metastases to central nervous system. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, ALBUTEROL, COMBIVENT, COUMADIN, HYDROCHLOROTHIAZIDE, MAGNESIUM SULPHATE. Patient was hospitalized. Patient died on 11/18/2005.

Cetuximab Side Effects Report #4843695-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Nov 14, 2005. Male patient, 66 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer, atrial fibrillation

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation

, blood creatinine increased, bronchitis

, cardio-respiratory arrest, dehydration, encephalopathy, malignant neoplasm progression, mental status changes. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, ALBUTEROL, COMBIVENT, COUMADIN, HYDROCHLOROTHIAZIDE, MAGNESIUM SULPHATE. Patient was hospitalized. Patient died on 11/18/2005.

Cetuximab Side Effects Report #5215962-2
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2007. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, nausea

. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PERCOCET, DEMEROL. Patient was hospitalized. Patient died on 09/15/2006.

Cetuximab Side Effects Report #5164819-4
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2006. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, nausea

. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PERCOCET, DEMEROL. Patient was hospitalized. Patient died on 09/15/2006.

Cetuximab Side Effects Report #5169369-7
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 02, 2005. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: fungus culture positive, gastrointestinal haemorrhage, hypoxia, malignant neoplasm progression, pneumonia

. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE. Patient was hospitalized. Patient died on 06/17/2005.

Cetuximab Side Effects Report #4761888-8
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 02, 2005. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia

. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE. Patient was hospitalized. Patient died on 06/17/2005.

Cetuximab Side Effects Report #4818456-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 02, 2005. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia

. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE, NEXIUM, CARDIZEM, PLAVIX, PERCOCET, BUMETANIDE, SINEMET. Patient was hospitalized. Patient died on 06/17/2005.

Cetuximab Side Effects Report #4870802-6
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2005. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: gastrointestinal obstruction, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, BENADRYL, FENTANYL, PERCOCET. Patient was hospitalized. Patient died on 11/07/2005.

Cetuximab Side Effects Report #4874535-1
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2005. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood potassium decreased, dysphonia, faecaloma, gastrointestinal obstruction, malignant neoplasm progression, non-small cell lung cancer, pneumonia

, respiratory failure, small intestinal obstruction. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, BENADRYL, FENTANYL, PERCOCET, ATENOLOL. Patient was hospitalized. Patient died on 11/05/2005.

Cetuximab Side Effects Report #4915116-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 02, 2005. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia

, malignant neoplasm progression, platelet count decreased. Cetuximab dosage: unknown. During the same period patient was treated with GEMCITABINE, DECADRON, LORTAB, LOPRESSOR, ACIPHEX. Patient was hospitalized. Patient died on 07/10/2005.

Cetuximab Side Effects Report #4829508-1
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 15, 2005. Female patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: deep vein thrombosis

, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with GEMCITABINE, DECADRON, LORTAB, LOPRESSOR, ACIPHEX. Patient was hospitalized. Patient died on 07/10/2005.

Cetuximab Side Effects Report #4922443-X
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 15, 2005. Female patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: deep vein thrombosis

, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with GEMCITABINE, DECADRON SRC, LORTAB, LOPRESSOR, ACIPHEX. Patient was hospitalized. Patient died on 07/10/2005.

Cetuximab Side Effects Report #5270122-4
Cetuximab side effect was reported by a Health Professional from GERMANY on Mar 19, 2007. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia

, pneumonia necrotising, pneumonitis. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE. Patient was hospitalized. Patient died on 10/08/2005.

Cetuximab Side Effects Report #4807607-8
Cetuximab side effect was reported by a Health Professional from GERMANY on July 01, 2005. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia

, pneumonia necrotising, respiratory failure. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE. Patient was hospitalized. Patient died on 10/08/2005.

Cetuximab Side Effects Report #4818455-7
Cetuximab side effect was reported by a Health Professional from GERMANY on July 01, 2005. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia

, pneumonia necrotising. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE. Patient was hospitalized. Patient died on 10/08/2005.

Cetuximab Side Effects Report #4939992-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 27, 2006. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dyspnoea, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with METFORMIN, MS CONTIN, MORPHINE SULPHATE, TRAZODONE, COLACE, FESO. Patient was hospitalized. Patient died on 01/26/2006.

Cetuximab Side Effects Report #5557321-9
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Dec 10, 2007. Female patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, malignant neoplasm progression, nausea

, pain

, retching, therapeutic agent toxicity. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, GRANISETRON, DOMPERIDONE, TRAMADOL, CYCLIZINE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4650714-3
Cetuximab side effect was reported by a Health Professional from on Apr 21, 2005. Female patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: confusional state, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE TARTRATE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4687589-2
Cetuximab side effect was reported by a Health Professional from on Apr 21, 2005. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: confusional state, headache

, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE TARTRATE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4674263-1
Cetuximab side effect was reported by a Health Professional from on May 18, 2005. Female patient, 57 years of age, weighting 169.8 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: confusional state, headache

, malignant neoplasm progression, musculoskeletal stiffness, nausea

, photophobia. Cetuximab dosage: unknown. During the same period patient was treated with IRESSA, ALBUTEROL, PREMARIN, FOLIC ACID, NEXIUM, ASPIRIN, VITAMIN, HYOSCYAMINE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5269511-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Mar 15, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: gastrointestinal ulcer, haemoglobin decreased, malignant neoplasm progression, stress ulcer. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient died on 11/23/2006.

Cetuximab Side Effects Report #5278779-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Mar 26, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: gastrointestinal ulcer, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient died on 11/23/2006.

Cetuximab Side Effects Report #5307461-4
Cetuximab side effect was reported by a Consumer or non-health professional from GERMANY on Apr 25, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: lung disorder, lung infection, malignant neoplasm progression, non-small cell lung cancer, sepsis

. Cetuximab dosage: unknown. During the same period patient was treated with CISPLATIN, VINORELBINE. Patient was hospitalized. Patient died on 12/17/2005.

Cetuximab Side Effects Report #4918419-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Dec 20, 2005. Male patient, 55 years of age, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: coma, malignant neoplasm progression, respiratory distress. Cetuximab dosage: unknown. Patient was hospitalized. Patient died on 12/08/2005.

Cetuximab Side Effects Report #4742989-7
Cetuximab side effect was reported by a Health Professional from UNITED STATES on June 29, 2005. Male patient, 51 years of age, weighting 178.6 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood chloride decreased, blood sodium decreased, disease progression, embolism, haemoglobin decreased, malignant neoplasm progression, palpitations, pulmonary embolism

. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ATIVAN, COUMADIN, HYDROCHLOROTHIAZIDE, MORPHINE, PREDNISONE. Patient was hospitalized. Patient died on 07/18/2005.

Cetuximab Side Effects Report #5583135-X
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 03, 2008. Female patient, 49 years of age, weighting 112.4 lb, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, haemoglobin decreased, malignant neoplasm progression, sepsis

, stomatitis. Cetuximab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, BEVACIZUMAB. Patient was hospitalized. Patient died on 12/25/2007.

Cetuximab Side Effects Report #4667899-5
Cetuximab side effect was reported by a Health Professional from on Mar 24, 2003. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: inappropriate antidiuretic hormone secretion, malignant neoplasm progression, paralysis

. Cetuximab dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, GEMZAR, CELEXA, AMBIEN. Patient was hospitalized. Patient died on 11/14/2001.

Cetuximab Side Effects Report #4700437-7
Cetuximab side effect was reported by a Health Professional from on Mar 24, 2003. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: inappropriate antidiuretic hormone secretion, malignant neoplasm progression, metastases to central nervous system, paralysis

. Cetuximab dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, GEMZAR, CELEXA, AMBIEN, ZOFRAN, NEUPOGEN. Patient was hospitalized. Patient died on 11/14/2001.

Cetuximab Side Effects Report #5134891-6
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 09, 2006. Female patient, child 5 years of age, was diagnosed with nephroblastoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: ascites, dehydration, malignant neoplasm progression, vomiting. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, ASPIRIN. Patient was hospitalized. Patient died on 10/10/2006.

Cetuximab Side Effects Report #5483465-6
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2007. Female patient, child 5 years of age, was diagnosed with nephroblastoma and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: ascites, dehydration, malignant neoplasm progression, vomiting. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, ASPIRIN. Patient was hospitalized. Patient died on 10/10/2006.

Cetuximab Side Effects Report #5696574-3
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2008. Male patient, 48 years of age, weighting 191.6 lb, was diagnosed with neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: atelectasis, bronchospasm, laboratory test interference, lung abscess, lung consolidation, lymphadenopathy, malignant neoplasm progression, metastases to lung, pleural effusion. Cetuximab dosage: 500 MG/M2 EVERY 2 WEEKS IV. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, DOCUSATE, PROMETHAZINE W, SYMBICORT, ALBUTEROL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5904290-5
Cetuximab side effect was reported by a Health Professional from UNITED STATES on June 30, 2008. Male patient, weighting 222.7 lb, was diagnosed with neoplasm malignant and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: abdominal distension, malignant neoplasm progression, pleural effusion. Cetuximab dosage: 2 MG/100. During the same period patient was treated with DASATINIB, ARMOUR THYROID, CENTRUM, NORVASC, VITAMIN D, ASPIRIN, DIOVAN, GLUCOSAMINE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5123321-6
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2006. Male patient, 76 years of age, weighting 176.4 lb, was diagnosed with multiple myeloma

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, epistaxis, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with DECADRON, ARANESP. Patient was hospitalized. Patient died on 07/19/2006.

Cetuximab Side Effects Report #5131618-9
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Sept 01, 2006. Male patient, 76 years of age, weighting 176.4 lb, was diagnosed with multiple myeloma

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: acute myocardial infarction, asthenia, cardiac failure congestive, epistaxis, hypoxia, malignant neoplasm progression, mental impairment. Cetuximab dosage: unknown. During the same period patient was treated with DECADRON, ARANESP. Patient was hospitalized. Patient died on 07/19/2006.

Cetuximab Side Effects Report #5171643-5
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2006. Male patient, 76 years of age, weighting 176.4 lb, was diagnosed with multiple myeloma

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, epistaxis, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with DECADRON, ARANESP. Patient was hospitalized. Patient died on 07/19/2006.

Cetuximab Side Effects Report #6058773-0
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 28, 2009. Male patient, weighting 187.2 lb, was diagnosed with gastric cancer and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anaemia, anorexia, dyspnoea, fatigue, malignant neoplasm progression, nausea

, pain

. Cetuximab dosage: 250 MG/M2 WEEKLY IV DRIP. During the same period patient was treated with ALLOPURINOL, LEVOTHYROXINE, PERCOCET, AMBIEN, PRILOSEC. Patient died on 01/14/2009.

Cetuximab Side Effects Report #5602733-8
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 23, 2008. Male patient, 85 years of age, weighting 156.5 lb, was diagnosed with colorectal cancer metastatic, mineral supplementation, gastrooesophageal reflux disease, hypertension, medical diet, lipids increased and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, cardiac arrest

, cardiac failure congestive, malignant neoplasm progression, metabolic acidosis, pancytopenia, pleural effusion, pneumonitis. Cetuximab dosage: unknown. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, CALCIUM GLUCONATE, NEXIUM, VASOTEC, ZOCOR. Patient was hospitalized. Patient died on 11/05/2007.

Cetuximab Side Effects Report #5610911-7
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Jan 30, 2008. Male patient, 85 years of age, weighting 156.5 lb, was diagnosed with colorectal cancer metastatic, mineral supplementation, gastrooesophageal reflux disease, hypertension, medical diet, lipids increased and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: cardiac arrest

, electrolyte imbalance, malignant neoplasm progression, pancytopenia, pneumonia

, pneumonitis, sepsis

. Cetuximab dosage: unknown. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, CALCIUM GLUCONATE, NEXIUM, VASOTEC, ZOCOR. Patient was hospitalized. Patient died on 11/05/2007.

Cetuximab Side Effects Report #4648576-3
Cetuximab side effect was reported by a Health Professional from on Apr 26, 2005. Male patient, 76 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 04/24/2005.

Cetuximab Side Effects Report #4680842-8
Cetuximab side effect was reported by a Health Professional from on Apr 26, 2005. Male patient, 76 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: ascites, malignant neoplasm progression, pleural effusion, respiratory failure. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 04/24/2005.

Cetuximab Side Effects Report #4726970-X
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Apr 26, 2005. Male patient, 76 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: ascites, malignant neoplasm progression, pleural effusion, respiratory failure. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 04/24/2005.

Cetuximab Side Effects Report #5267245-2
Cetuximab side effect was reported by a Health Professional from GERMANY on Mar 08, 2007. Male patient, 70 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, dyspnoea, lower respiratory tract infection, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5164008-3
Cetuximab side effect was reported by a Health Professional from GERMANY on June 19, 2006. Male patient, 70 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, dyspnoea, lower respiratory tract infection, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5413868-7
Cetuximab side effect was reported by a Health Professional from GERMANY on Aug 07, 2007. Male patient, 70 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: dehydration, dyspnoea, lower respiratory tract infection, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5407415-3
Cetuximab side effect was reported by a Health Professional from UNITED STATES on Aug 06, 2007. Male patient, 68 years of age, weighting 152.1 lb, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: intestinal obstruction, malignant neoplasm progression. Cetuximab dosage: 824 MG WEEKLY,INITIATED 17-AUG-2005.. During the same period patient was treated with CAPECITABINE, IRINOTECAN. Patient was hospitalized. Patient died on 01/26/2006.

Cetuximab Side Effects Report #5130461-4
Cetuximab side effect was reported by a Consumer or non-health professional from CANADA on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypomagnesaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient died on 02/25/2005.

Cetuximab Side Effects Report #5138529-3
Cetuximab side effect was reported by a Consumer or non-health professional from CANADA on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypomagnesaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient died on 02/25/2005.

Cetuximab Side Effects Report #4592741-0
Cetuximab side effect was reported by a Health Professional from on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, colon cancer metastatic, confusional state, dyspnoea, hypocalcaemia, hypomagnesaemia, lethargy, malignant neoplasm progression, nausea

. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4633077-9
Cetuximab side effect was reported by a Consumer or non-health professional from on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, dyspnoea, hypocalcaemia, hypomagnesaemia, lethargy, malignant neoplasm progression, nausea

. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4841710-1
Cetuximab side effect was reported by a Consumer or non-health professional from CANADA on Feb 21, 2005. Male patient, 65 years of age, weighting 253.5 lb, was diagnosed with colorectal cancer metastatic, hypertension, sedation, rash

and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: asthenia, haemoglobin decreased, hypoalbuminaemia, hypocalcaemia, hypomagnesaemia, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with METOPROLOL, ALTACE, ZOPICLONE, POLYSPORIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4935711-2
Cetuximab side effect was reported by a Health Professional from UNITED KINGDOM on Dec 28, 2005. Male patient, 65 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: cardiac failure, cholangitis, jaundice cholestatic, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, TROPISETRON, ATROPINE, TAVEGIL, FUROSEMIDE, HYDROCHLOROTHIAZIDE, CILAZAPRIL, THIAMAZOLE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #4945798-9
Cetuximab side effect was reported by a Health Professional from UNITED KINGDOM on Dec 28, 2005. Male patient, 65 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: bile duct stenosis, cardiac failure, cholangitis, jaundice cholestatic, malignant neoplasm progression. Cetuximab dosage: unknown. During the same period patient was treated with IRINOTECAN, TROPISETRON, ATROPINE, TAVEGIL, FUROSEMIDE, HYDROCHLOROTHIAZIDE, CILAZAPRIL, THIAMAZOLE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5951881-1
Cetuximab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 11, 2008. Male patient, 62 years of age, was diagnosed with colorectal cancer metastatic and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: colorectal cancer metastatic, diarrhoea, haemoglobin decreased, malignant neoplasm progression, stomatitis. Cetuximab dosage: unknown. During the same period patient was treated with FOLINIC ACID, IRINOTECAN, FLUOROURACIL. Patient was hospitalized. Patient died.

Cetuximab Side Effects Report #4576812-0
Cetuximab side effect was reported by a Consumer or non-health professional from on Feb 03, 2005. Female patient, 58 years of age, weighting 123.5 lb, was diagnosed with colorectal cancer metastatic, cough, hypertension, hypercholesterolaemia and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, ascites, colorectal cancer metastatic, cough, dyspnoea, fatigue, malignant neoplasm progression, oedema peripheral, tachycardia. Cetuximab dosage: INITIATED ON 26-OCT-04 (LD=600MG). D/C STUDY ON 23-NOV-04. PT REC'D 2 DOSES.. During the same period patient was treated with LEVOFLOXACIN, FOSINOPRIL, RENEDIL, ATORVASTATIN. Patient was hospitalized. Patient died on 11/30/2004.

Cetuximab Side Effects Report #4592809-9
Cetuximab side effect was reported by a Consumer or non-health professional from on Feb 03, 2005. Female patient, 58 years of age, weighting 123.5 lb, was diagnosed with colorectal cancer metastatic, cough, hypertension, hypercholesterolaemia and was treated with Cetuximab. After drug was administered, patient experienced the following side effects: anorexia, ascites, colorectal cancer metastatic, cough, disease progression, dyspnoea, fatigue, malignant neoplasm progression, oedema peripheral. Cetuximab dosage: INITIATED ON 26-OCT-04 (LD=600MG). D/C STUDY ON 23-NOV-04. PT REC'D 2 DOSES.. During the same period patient was treated with LEVOFLOXACIN, FOSINOPRIL, RENEDIL, ATORVASTATIN. Patient was hospitalized. Patient died on 11/30/2004.

Cetuximab and malignant neoplasm progression

SideEffects101.com

Cetuximab and malignant neoplasm progression Patient Reports February 11, 2012

side effects of Cetuximab